T. Torelli

Tremelimumab and durvalumab as neoadjuvant or non-operative management strategy of patients with microsatellite instability-high resectable gastric or gastroesophageal junction adenocarcinoma: the INFINITY study by GONO

A. Raimondi, Sara Lonardi, Sabina Murgioni et al. · Annals of Oncology · 2024 · 72 citations · Full text

Medicine, Oncology, Pathology +17

Monocytes in leukapheresis products affect the outcome of CD19–targeted CAR T-cell therapy in patients with lymphoma

Cristiana Carniti, Nicole Caldarelli, Luca Agnelli et al. · Blood Advances · 2024 · 25 citations · Full text

Life Sciences, Hematology, Immunology +16

Early downmodulation of tumor glycolysis predicts response to fasting-mimicking diet in triple-negative breast cancer patients

Francesca Ligorio, Andrea Vingiani, T. Torelli et al. · Cell Metabolism · 2024 · 21 citations

Medicine, Cancer Biology, Oncology +16

PEOPLE (NTC03447678), a phase II trial to test pembrolizumab as first-line treatment in patients with advanced NSCLC with PD-L1 <50%: a multiomics analysis

Giuseppe Lo Russo, Arsela Prelaj, James M. Dolezal et al. · Journal for ImmunoTherapy of Cancer · 2023 · 18 citations · Full text

Medicine, Immunology, Oncology +17